Hangzhou Biotest Biotech Co Ltd (688767) — Cash Flow Quality Index
Hangzhou Biotest Biotech Co Ltd (688767) has a Cash Flow Quality Index of 2.88x as of September 2025. Operating cash flow of CN¥28.39 Million exceeds net income of CN¥9.86 Million, indicating high earnings quality where cash backs reported profits. Explore 688767 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hangzhou Biotest Biotech Co Ltd Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Hangzhou Biotest Biotech Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688767 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Hangzhou Biotest Biotech Co Ltd (2017–2025)
Year-by-year earnings quality comparison for Hangzhou Biotest Biotech Co Ltd. For live market cap and the full company financial profile, see market value of Hangzhou Biotest Biotech Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.16x | CN¥106.47 Million | CN¥49.25 Million | ▲ +179.8% |
| 2024 | 0.77x | CN¥128.83 Million | CN¥166.78 Million | ▼ -37.3% |
| 2023 | 1.23x | CN¥131.38 Million | CN¥106.61 Million | ▲ +35.6% |
| 2022 | 0.91x | CN¥703.21 Million | CN¥773.58 Million | ▼ -16.3% |
| 2021 | 1.09x | CN¥908.12 Million | CN¥835.76 Million | ▲ +6.0% |
| 2020 | 1.03x | CN¥446.07 Million | CN¥434.97 Million | ▲ +11.6% |
| 2019 | 0.92x | CN¥25.67 Million | CN¥27.94 Million | ▼ -18.2% |
| 2018 | 1.12x | CN¥21.17 Million | CN¥18.85 Million | ▼ -46.7% |
| 2017 | 2.11x | CN¥7.07 Million | CN¥3.36 Million | — |